Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Tag: Drug Quality Control
Kazakhstan reaches important milestone of its National Drug Policy development
At the end of 2017, the Minister of Health of the Republic of Kazakhstan signed the order approving the Kazakhstan National Formulary
Russian President signs the Federal Law on introduction of drug labeling
Russian President Vladimir Putin signed the Federal Law “On amendments to the Federal law "On Circulation of medicines.”
The Federation Council of Russia ratifies the MEDICRIME Convention
Russian senators have approved the Federal Law “On ratification of the Council of Europe Convention on the counterfeiting of medical products”
Russia ratifies the Convention on counterfeiting of medicinal products
The State Duma ratified the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health
FAS Russia reports on the most frequent violations in healthcare sector
The Federal Antimonopoly Service of Russia participates in the reform of control and oversight activities
Dark web drug market evolves at a rapid pace in Europe
The illegal drug trade on the dark web is growing rapidly despite authorities shutting down major market sites
WHO published its study report on falsified medical products
An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO
EMA launched an improved version of EudraVigilance information system
The European Medicines Agency has launched a new and improved version of EudraVigilance, the European information system
Kazakhstan’s Center for Expertise of Medicines joined IPRF and IGDRP
The meetings of the Management Committee of IPRF and the Steering Committee of IGDRP approved the admission of the Kazakhstan’s Center to IPRF and IGDRP
Russian State Duma approves the drug labeling bill in the first reading
Russia introduces total control over the quality of drugs
FDA allows eight European authorities to conduct GMP inspections
U.S. Food and Drug Administration will recognize eight European drug regulatory authorities as capable of conducting inspections of manufacturing facilities
The Chinese Government set new rules to speed up drug approvals
China will encourage innovation in drugs and medical equipment by expanding the reform of review and approval system in the medical sector
EMA started a survey to understand the awareness about side effects of medicines
The European Medicines Agency (EMA) launches survey to assess whether patients and doctors are aware of the arrangements for reporting of side effects.
Roszdravnadzor detected and recalled 2 counterfeit drugs in H1
The Federal Service for Surveillance in Healthcare released the results of state control (surveillance) over the circulation of medicinal products for H1 2017
Roszdravnadzor seizes counterfeit Xymelin
the Federal Service for Surveillance in Healthcare informs on the need to withdraw from circulation a counterfeit medicinal product “Xymelin
Bayer recieved EU marketing authorization for Stivarga
Bayer announced the European Commission (EC) has granted marketing authorization for Stivarga® (regorafenib)
Page 5 of 8
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
API Ropivacaine Hydrochloride
for production of sterile dosage forms registered in Russia
pharmaceutical salt is exclusively made of highly purified vacuum salt
PHARMASAL API complies with
• Ph. EUR, BP, US, JP, RU
• Prequalified Active Pharmaceutical Ingredients
PHARMASAL HD complies with
• Ph. EUR, BP, US, JP, RU
A product of Salinen Austria AG
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
EAEU may allow to register empty primary packages as medical...
Inspection of Foreign Manufacturers of Veterinary Products
FDA Approved XCOPRI to Treat Partial-Onset Seizures
BioCity UK Life Science Start-Up Report Reveals ‘Baby Boom’ ...
Subscribe to Newsletter!
© GMP news